Orbimed Advisors LLC, Director at Sionna Therapeutics, Inc. (SION), sold 85,918 shares at $44.86 ($3.9M) on 2026-07-07, disclosed to the SEC on 2026-07-09.
Scheduled sale ($3.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BRVE | BUY | 2026-08-11 | $34.9M | — | Filing → |
| SCTX | BUY | 2026-07-29 | $15.0M | — | Filing → |
| SION | SELL | 2026-07-02 | $5.3M | — | Filing → |